OraSure Technologies

OverviewSuggest Edit

OraSure Technologies develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The Company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. In addition, the Company offers oral fluid collection devices to collect, stabilize, transport, and store samples of genetic material. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing, immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications, an oral fluid HIV-1 confirmatory test and rapid point-of-care saliva alcohol test.

TypePublic
Founded1987
HQBethlehem, USMap
Websiteorasure.com
Employee Ratings3.1More
View Jobs (14)

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2019)377
Job Openings14
Revenue (FY, 2018)$181.7 M(+9%)
Share Price (Mar 2019)$10.8 (-6%)

OraSure Technologies Office Locations

OraSure Technologies has an office in Bethlehem
Bethlehem, US (HQ)
220 E 1st St
Bethlehem, US
1745 Eaton Ave
Bethlehem, US
150 Webster St
Show all (3)
Report incorrect company information

OraSure Technologies Financials and Metrics

OraSure Technologies Revenue

Embed Graph
View revenue for all periods
OraSure Technologies's revenue was reported to be $181.74 m in FY, 2018
USD

Revenue (FY, 2018)

181.7m

Gross profit (FY, 2018)

113.6m

Gross profit margin (FY, 2018), %

62.5%

Net income (FY, 2018)

20.4m

EBIT (FY, 2018)

28.4m

Market capitalization (22-Mar-2019)

664.1m

Closing stock price (22-Mar-2019)

10.8

Cash (31-Dec-2018)

88.4m
OraSure Technologies's current market capitalization is $664.1 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

98.9m106.5m119.7m128.2m167.1m181.7m

Revenue growth, %

13%8%12%7%

Cost of goods sold

40.4m39.8m39.4m40.2m68.1m68.1m

Gross profit

58.6m66.6m80.3m88.0m99.0m113.6m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

24.7m23.5m26.4m27.8m27.1m30.4m29.9m29.1m31.4m32.3m32.5m40.2m42.3m42.0m43.6m45.9m

Cost of goods sold

9.7m9.6m10.4m9.1m10.1m9.7m9.2m8.8m10.3m9.6m12.2m14.7m17.7m17.5m17.7m17.3m

Gross profit

14.9m13.9m16.0m18.7m17.0m20.7m20.7m20.3m21.1m22.7m20.3m25.5m24.6m24.5m25.9m28.5m

Gross profit Margin, %

61%59%61%67%63%68%69%70%67%70%62%63%58%58%59%62%
show all
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

93.2m92.9m94.1m108.0m71.0m88.4m

Inventories

11.4m15.8m13.2m11.8m19.3m22.9m

Current Assets

119.6m131.2m136.7m156.4m221.9m219.3m

PP&E

17.9m17.9m20.1m20.0m21.4m24.3m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

82.6m84.2m75.8m93.9m85.5m83.4m100.7m94.6m105.7m111.7m120.9m104.9m76.8m64.0m71.0m78.1m

Inventories

12.0m12.0m13.2m14.8m15.6m15.7m15.0m12.3m11.4m12.1m12.7m14.5m16.9m20.9m20.6m19.9m

Current Assets

111.4m111.8m115.8m130.0m123.2m125.3m141.8m134.3m146.4m150.7m180.5m205.7m209.3m196.8m202.2m207.9m

PP&E

18.0m17.8m18.5m18.0m17.6m17.9m17.8m20.2m20.2m20.1m20.1m20.3m21.5m23.0m23.9m24.4m
show all
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(11.2m)(4.6m)8.2m19.7m30.9m20.4m

Depreciation and Amortization

6.6m6.3m5.7m5.7m6.4m6.5m

Inventories

1.3m(4.4m)2.3m1.5m(7.4m)(3.9m)

Accounts Payable

1.5m2.2m(2.6m)46.0k5.2m208.0k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(17.4m)(5.6m)(3.1m)(2.0m)113.0k2.1m3.6m2.4m6.3m12.5m12.4m17.9m23.6m(2.1m)2.0m10.1m

Depreciation and Amortization

4.8m1.5m3.1m4.7m1.4m2.8m4.3m1.4m2.8m4.2m1.4m2.9m4.6m1.9m3.7m5.6m

Inventories

745.0k(586.0k)(1.8m)(3.4m)57.0k35.0k633.0k990.0k1.9m1.2m(893.0k)(2.7m)(4.9m)(1.7m)(1.4m)(649.0k)

Accounts Payable

497.0k(683.0k)(179.0k)(284.0k)(2.1m)(2.5m)(72.0k)758.0k(782.0k)(125.0k)2.6m4.7m4.6m(1.1m)(193.0k)(2.2m)
show all
USDY, 2018

Revenue/Employee

482.1k

Financial Leverage

1.1 x
Show all financial metrics

OraSure Technologies Operating Metrics

FY, 2016

Facilities

2

Patents (US)

29
Show all operating metrics

OraSure Technologies Revenue Breakdown

Embed Graph

OraSure Technologies revenue breakdown by business segment: 25.1% from DNAG and 74.9% from OSUR

Report incorrect company information

Competitors

Baystate Health
Healthcare - Subsidiary
Hygeia
Healthcare - Public
CareFamily
Healthcare - Private
Luitpold Pharmaceuticals
Healthcare - Private
Compare competitors

OraSure Technologies Online and Social Media Presence

Embed Graph
Report incorrect company information

OraSure Technologies News and Updates

January 10, 2019

OraSure Technologies Earnings Conference Call Invitation

2018 Fourth Quarter Earnings Conference Call Wednesday, February 6, 2019, 5:00 p.m. ET 2018 Fourth Quarter Earnings Conference Call Wednesday, February 6, 2019, 5:00 p.m. ET
January 04, 2019

OraSure Technologies, Inc. Announces Two Acquisitions and Reaffirms Fourth Quarter 2018 Guidance

CoreBiome leverages OraSure’s leadership position in microbiome sample collection with end-to-end laboratory services for sample processing, sequencing, and bioinformatics
January 02, 2019

OraSure Technologies, Inc.: Updated Release to Clarify Timing of Presentation

OraSure Technologies to Present at the 37th Annual J.P. Morgan Healthcare Conference OraSure Technologies to Present at the 37th Annual J.P. Morgan Healthcare Conference
January 02, 2019

OraSure Technologies to Present at the 37th Annual J.P. Morgan Healthcare Conference

BETHLEHEM, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 37TH Annual J.P. Morga…
December 10, 2018

OraSure Technologies Announces 2019 Annual Meeting Date

BETHLEHEM, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2019 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 21, 2019.  This will be a completely virtual meeting, conducted as a li…
November 29, 2018

OraSure Technologies to Ring NASDAQ Stock Market Opening Bell in Honor of World AIDS Day

OraSure Working to End AIDS on a Global Scale OraSure Working to End AIDS on a Global Scale
Show more
Report incorrect company information

 OraSure Technologies Frequently Asked Questions

  • When was OraSure Technologies founded?

    OraSure Technologies was founded in 1987.

  • How many employees does OraSure Technologies have?

    OraSure Technologies has 377 employees.

  • What is OraSure Technologies revenue?

    Latest OraSure Technologies annual revenue is $181.7 m.

  • What is OraSure Technologies revenue per employee?

    Latest OraSure Technologies revenue per employee is $482.1 k.

  • Who are OraSure Technologies competitors?

    Competitors of OraSure Technologies include Baystate Health, Hygeia and CareFamily.

  • Where is OraSure Technologies headquarters?

    OraSure Technologies headquarters is located at 220 E 1st St, Bethlehem.

  • Where are OraSure Technologies offices?

    OraSure Technologies has an office in Bethlehem.

  • How many offices does OraSure Technologies have?

    OraSure Technologies has 3 offices.

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Learn more